[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 399 9500", "website": "https://www.tscan.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 that is in Phase I clinical trial for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. It also advanced TS-102 into IND-enabling activities. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors. It has collaborations with Novartis Institutes for BioMedical Research, Inc. to discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 194, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gavin  MacBeath Ph.D.", "age": 53, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1025727, "exercisedValue": 0, "unexercisedValue": 207573}, {"maxAge": 1, "name": "Dr. Chrystal U. Louis M.D., M.P.H.", "age": 47, "title": "Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 550125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen J. Elledge Ph.D.", "title": "Co-Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tomasz  Kula Ph.D.", "title": "Co-Founder & Member of Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Justin  McCue Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zoran  Zdraveski J.D., Ph.D.", "age": 53, "title": "Chief Legal & Strategy Officer and Company Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 657200, "exercisedValue": 0, "unexercisedValue": 85247}, {"maxAge": 1, "name": "Ms. Ann  Hargraves", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shrikanta  Chattopadhyay M.D.", "title": "Senior VP & Head of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ray  Lockard M.B.A.", "title": "Senior Vice President & Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Murray", "title": "Senior VP & Head of Development Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.79, "open": 1.87, "dayLow": 1.73, "dayHigh": 1.89, "regularMarketPreviousClose": 1.79, "regularMarketOpen": 1.87, "regularMarketDayLow": 1.73, "regularMarketDayHigh": 1.89, "payoutRatio": 0.0, "beta": 0.906, "forwardPE": -1.3488373, "volume": 575060, "regularMarketVolume": 575060, "averageVolume": 416131, "averageVolume10days": 327110, "averageDailyVolume10Day": 327110, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 98467648, "fiftyTwoWeekLow": 1.711, "fiftyTwoWeekHigh": 9.69, "priceToSalesTrailing12Months": 34.967205, "fiftyDayAverage": 2.3201, "twoHundredDayAverage": 4.842125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -94261312, "profitMargins": 0.0, "floatShares": 37137033, "sharesOutstanding": 52314000, "sharesShort": 2225112, "sharesShortPriorMonth": 1818854, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.039300002, "heldPercentInsiders": 0.00822, "heldPercentInstitutions": 0.90586, "shortRatio": 5.8, "shortPercentOfFloat": 0.0476, "impliedSharesOutstanding": 5143130, "bookValue": 4.258, "priceToBook": 0.40864256, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -127499000, "trailingEps": -1.14, "forwardEps": -1.29, "enterpriseToRevenue": -33.473, "enterpriseToEbitda": 0.721, "52WeekChange": -0.7452416, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 1.74, "targetHighPrice": 15.0, "targetLowPrice": 3.0, "targetMeanPrice": 9.71429, "targetMedianPrice": 10.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 290110016, "totalCashPerShare": 5.126, "ebitda": -130713000, "totalDebt": 97381000, "quickRatio": 8.068, "currentRatio": 8.141, "totalRevenue": 2816000, "debtToEquity": 40.412, "revenuePerShare": 0.05, "returnOnAssets": -0.26198, "returnOnEquity": -0.65078, "grossProfits": -2030000, "freeCashflow": -68974248, "operatingCashflow": -110822000, "revenueGrowth": -0.908, "grossMargins": -0.72088, "ebitdaMargins": 0.0, "operatingMargins": -55.20602, "financialCurrency": "USD", "symbol": "TCRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1741985840, "regularMarketTime": 1741982400, "exchange": "NGM", "messageBoardId": "finmb_583057578", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "TScan Therapeutics, Inc.", "longName": "TScan Therapeutics, Inc.", "epsTrailingTwelveMonths": -1.14, "epsForward": -1.29, "epsCurrentYear": -1.1295, "priceEpsCurrentYear": -1.5405046, "fiftyDayAverageChange": -0.58010006, "fiftyDayAverageChangePercent": -0.25003234, "twoHundredDayAverageChange": -3.102125, "twoHundredDayAverageChangePercent": -0.6406536, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626442200000, "marketState": "CLOSED", "corporateActions": [], "regularMarketChangePercent": -2.7932935, "regularMarketPrice": 1.74, "postMarketChangePercent": 2.87356, "postMarketPrice": 1.79, "postMarketChange": 0.05, "regularMarketChange": -0.049999952, "regularMarketDayRange": "1.73 - 1.89", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 416131, "fiftyTwoWeekLowChange": 0.029000044, "fiftyTwoWeekLowChangePercent": 0.016949179, "fiftyTwoWeekRange": "1.711 - 9.69", "fiftyTwoWeekHighChange": -7.95, "fiftyTwoWeekHighChangePercent": -0.82043344, "fiftyTwoWeekChangePercent": -74.524155, "displayName": "TScan Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]